Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-25 @ 4:10 AM
NCT ID:
NCT00260520
Eligibility Criteria:
Inclusion Criteria:
* Previous severe preeclampsia
* Previous severe fetal growth restriction
* Heterozygous Factor V Leiden
* Heterozygous G20210A prothrombin gene mutations
Exclusion Criteria:
* renal disease
* chronic hypertension
* preexisting diabetes mellitus
* homozygosity for Factor V Leiden
* homozygosity for prothrombin G20210A mutation
* hyperhomocysteinemia
* protein C deficency
* protein S deficency
* antithrombin deficiency
* positive anticardiolipin antibodies
* positive lupus anticoagulant
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
40 Years
Study:
NCT00260520
Study Brief:
Protocol Section:
NCT00260520